GREETING PROFILE PRODUCTS INVESTOR INFORMATION PRESS RELEASE
October 05, 2004 Notification of finalization of agreement for exclusive import and distribution contract with Volcano Therapeutics
As of 27th September, 2004, an exclusive import and distribution contract for the next generation intravascular ultrasound imaging modality with catheter for coronary applications and non-exclusive importation and distribution contract for the current intravascular ultrasound imaging modality with catheter has been finalized with Volcano Therapeutics.
Importation and sales contract details
Agreement partner Volcano Therapeutics (a US Corporation)
Term of contract Commencing 1st February, 2005, term will last 5 years from regulatory approval of the next generation of products.  A provision for extension of term exists.
Reason for conclusion of contract As a pioneer in the field of the intravascular ultrasound imaging and catheter market, Goodman has created a unique market and developed significant business operations over many years of dynamic management.  Under these conditions Goodman has constantly and diligently gathered information relating to new products.
The reasoning for completing the exclusive import and distribution contract with Volcano Therapeutics is that their intravascular ultrasound imaging modality and catheter meet the needs of the medical environment with the value added, new functionality (analytical software) of the equipment.
The contract was concluded given that the products contribute in line with Goodman's managerial guidelines of 'contributing to the general health of people and supporting the medical technology through medical equipment for the continually aging population.'
Agreement items Next generation intravascular ultrasound imaging modality and catheter (including existing products)
Features Product characteristics include the remarkable evolving qualities of image analysis functionality.Current modalities currently use tomographical images of the vessel for purposes of diagnosis “displaying grayscale (black and white image) as accurately as possible”, which then relies on the Doctor’s experience and skill to diagnose lesions, making a homogeneous standard in diagnosis difficult.
The addition to the products of the Virtual Histology? software developed at the Cleveland Clinic allows for radiofrequency signals to be analyzed simultaneously with the formation of Grayscale.  Plaque components are then associated into 4 colors and the color coded plaque characteristics are then displayed over the grayscale image.
With the inclusion of this function, it is expected that homogeneous high level diagnosis can be established for data traditionally diagnosed by a physician’s experience and skill.  Through the 3 dimensional display of the tomographic images, the physician can comprehend the condition of the lesion position in 3 dimensions, allowing treatment methods to be determined.
Furthermore, previous diagnosis by conventional equipment required extra labor to calculate vessel diameter, yet the inclusion of automatically defined functionality contributes to optimizing diagnosis.
Forecast Having fostered its position as market leader for many years, Goodman looks forward to contributing to the expansion of its performance through the utilization of its fortes of know-how, sales networks and established relationships with medical institutions.
Virtual Histology™

Virtual Histology™, developed by Cleveland Clinic, is software that color codes plaque components over a grayscale image.  During intravascular ultrasound, radiofrequency signals are attained and using autoregressive backscatter analysis automatically define atherosclerosis into 4 plaque components and displays said results in real time.
Current intravascular ultrasound equipment is limited to displaying vessel tomography in black and white imaging (grayscale).  When constructing vessel tomography using ultrasonic backscattered signals, calcified and fibrous plaque strongly reflect signals and generally appear bright (white).  Tissue that poorly reflect signals are diagnosed as being typically lipid pools or plaque containing a mixture of fatty plaque.

Copyright© 2004 Goodman Co., Ltd. All rights reserved.